BioNTech SE (BNTX) Total Current Liabilities (2018 - 2026)

BioNTech SE has reported Total Current Liabilities for 8 years, with the latest figure at $2.5 billion in Q4 2025.

• Quarterly Total Current Liabilities fell 7.51% year-over-year to $2.5 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.5 billion (down 7.51% YoY) and the FY2025 annual result came in at $2.4 billion, down 10.23% from the prior year.
• Total Current Liabilities retreated to $2.5 billion in Q4 2025 per BNTX's latest filing, from $2.6 billion in the prior quarter.
• Over five years, Total Current Liabilities peaked at $5.8 billion in Q3 2021 and troughed at $1.6 billion in Q1 2021.
• A 5-year average of $2.9 billion and a median of $2.6 billion in 2025 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2021 and 2023: Total Current Liabilities soared 1743.58% in 2021, then tumbled 61.52% in 2023.
• Over 5 years, Total Current Liabilities stood at $4.0 billion in 2021, then dropped by 24.42% to $3.0 billion in 2022, then fell by 26.0% to $2.2 billion in 2023, then increased by 21.03% to $2.7 billion in 2024, then retreated by 7.51% to $2.5 billion in 2025.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $2.5 billion, $2.6 billion, and $2.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.